Clinical TrialID 6736

Alpha-bisabolol for Onychomycosis Treatment

NCT04940520

Onychomycosis

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
6736
Evidence Id
6736
Core Evidence Id
6736
Source Clinical Trial Id
6724
Herb2 Clinical Trial Id
HBCT006724
Nct Id
NCT04940520
Title
Alpha-bisabolol for Onychomycosis Treatment
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Onychomycosis
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
BIOLOGICAL: Drug recommended by the Brazilian Society of Dermatology|COMBINATION_PRODUCT: Alpha bisabolol product and laser|BIOLOGICAL: Alpha bisabolol product
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Single
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
60
Outcome Measure
Injury area analysis, All participants will have their nails photographed every 15 days for treatment control and evolution. Theses areas will be compared using the Image J program., 2 months
Sponsor Collaborator
Universidade do Vale do Sapucai
Funded By
OTHER
Location
Vale do Sapucaí University, Pouso Alegre, Minas Gerais, 37550-000, Brazil
Other Id
Onicomicose
Start Date
2020-06-01
Primary Completion Date
2020-11-30
Completion Date
2021-05-01
First Posted
2021-06-25
Results First Posted
Last Update Posted
2021-06-30
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04940520
Title Cn
Title En
Alpha-bisabolol for Onychomycosis Treatment
Bilingual Status
semi_complete